Dutasteride: prices and alternatives
Indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention, and reduce the need for BPH-related surgery. Not approved for prevention of prostate cancer.
4 products with this active ingredient from 4 manufacturers. Official prices from 27.5 to 313 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.


